Search research articles
Contact Us
Filters
Showing results (91-100 of 112) with videos related to
Page
of 12
Sort By:
Journal of Neurology
|
May 16, 2009
Multiple sclerosis patients' benefit-risk preferences: serious adverse event risks versus treatment efficacy
F Reed Johnson, George Van Houtven, Semra Ozdemir, et al.
Vaccine
|
August 26, 2011
Healthy-days time equivalents for outcomes of acute rotavirus infections
A Brett Hauber, Robbin Itzler, F Reed Johnson, et al.
The Patient
|
November 9, 2021
Women's Willingness to Accept Risks of Medication for Inflammatory Bowel Disease During Pregnancy
Tatyana Kushner, Angelyn Fairchild, F Reed Johnson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 18, 2019
Variation Among Patients With Crohn's Disease in Benefit vs Risk Preferences and Remission Time Equivalents
Meenakshi Bewtra, Shelby D Reed, F Reed Johnson, et al.
Therapeutic Innovation & Regulatory Science
|
September 21, 2018
Patient Engagement at a Tipping Point-The Need for Cultural Change Across Patient, Sponsor, and Regulator Stakeholders: Insights From the DIA Conference, "Patient Engagement in Benefit Risk Assessment Throughout the Life Cycle of Medical Products"
Meredith Y Smith, Tarek A Hammad, Marilyn Metcalf, et al.
Alzheimer Disease and Associated Disorders
|
August 30, 2008
Older Americans' risk-benefit preferences for modifying the course of Alzheimer disease
A Brett Hauber, F Reed Johnson, Howard Fillit, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 15, 2011
Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force
John F P Bridges, A Brett Hauber, Deborah Marshall, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 12, 2009
Using the incremental net benefit framework for quantitative benefit-risk analysis in regulatory decision-making--a case study of alosetron in irritable bowel syndrome
Larry D Lynd, Mehdi Najafzadeh, Lindsey Colley, et al.
The American Journal of Gastroenterology
|
April 17, 2025
Quantifying Patient Preferences for Risk Tolerance With Novel Dual Biologic Therapies for Inflammatory Bowel Disease
Jui-Chen Yang, Ellen M Janssen, Matthew J Wallace, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 23, 2013
Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force
F Reed Johnson, Emily Lancsar, Deborah Marshall, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 112) with videos related to
Sort By:
Page
of 12
Journal of Neurology
|
May 16, 2009
Multiple sclerosis patients' benefit-risk preferences: serious adverse event risks versus treatment efficacy
F Reed Johnson, George Van Houtven, Semra Ozdemir, et al.
Vaccine
|
August 26, 2011
Healthy-days time equivalents for outcomes of acute rotavirus infections
A Brett Hauber, Robbin Itzler, F Reed Johnson, et al.
The Patient
|
November 9, 2021
Women's Willingness to Accept Risks of Medication for Inflammatory Bowel Disease During Pregnancy
Tatyana Kushner, Angelyn Fairchild, F Reed Johnson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 18, 2019
Variation Among Patients With Crohn's Disease in Benefit vs Risk Preferences and Remission Time Equivalents
Meenakshi Bewtra, Shelby D Reed, F Reed Johnson, et al.
Therapeutic Innovation & Regulatory Science
|
September 21, 2018
Patient Engagement at a Tipping Point-The Need for Cultural Change Across Patient, Sponsor, and Regulator Stakeholders: Insights From the DIA Conference, "Patient Engagement in Benefit Risk Assessment Throughout the Life Cycle of Medical Products"
Meredith Y Smith, Tarek A Hammad, Marilyn Metcalf, et al.
Alzheimer Disease and Associated Disorders
|
August 30, 2008
Older Americans' risk-benefit preferences for modifying the course of Alzheimer disease
A Brett Hauber, F Reed Johnson, Howard Fillit, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 15, 2011
Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force
John F P Bridges, A Brett Hauber, Deborah Marshall, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 12, 2009
Using the incremental net benefit framework for quantitative benefit-risk analysis in regulatory decision-making--a case study of alosetron in irritable bowel syndrome
Larry D Lynd, Mehdi Najafzadeh, Lindsey Colley, et al.
The American Journal of Gastroenterology
|
April 17, 2025
Quantifying Patient Preferences for Risk Tolerance With Novel Dual Biologic Therapies for Inflammatory Bowel Disease
Jui-Chen Yang, Ellen M Janssen, Matthew J Wallace, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 23, 2013
Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force
F Reed Johnson, Emily Lancsar, Deborah Marshall, et al.
Page
of 12